iSpecimen Secures $5.5 Million in Funding to Support Market Expansion
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 30 2025
0mins
Source: Newsfilter
- Funding Agreement: iSpecimen has entered into a securities purchase agreement with accredited investors for approximately $5.5 million in gross proceeds, which will be utilized for marketing and working capital, thereby enhancing the company's market competitiveness.
- Preferred Stock Issuance: The company will issue 6,875 shares of newly designated Series C Convertible Preferred Stock at a price of $800 per share, with the offering expected to close on December 31, 2025, further optimizing its capital structure.
- Conversion Mechanism: Each share of Preferred Stock is convertible into common stock at a stated value of $1,000, with a conversion price set at 85% of the common stock's closing price, providing investors with potential capital appreciation opportunities.
- Compliance Statement: This offering complies with Section 4(a)(2) of the Securities Act of 1933, ensuring that securities are offered only to accredited investors, which reduces legal risks and enhances investor confidence.
Analyst Views on ISPC
About ISPC
iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
